PHP89 Use of low-cost Generic Programs in a Nationally representative Medicare Population and implications for Quality initiatives  by Pauly, N. & Brown, J.
 VA L U E  I N  H E A LT H  1 8  ( 2 0 1 5 )  A 1 – A 3 0 7  A85
OBJECTIVES: Economic evaluations (EE) are ubiquitous and growing in importance 
with increasing demand for healthcare services. However, healthcare decision 
makers often do not use this evidence when making decisions. Previous research 
has shown several factors influence the use of EE, such as credibility, complexity, 
and timeliness. However, no research has examined the relative importance of 
these factors in making EE more valuable as a service. This research shows what 
factors are most important to healthcare professionals/ administrators/research-
ers, when examining research using EE. METHODS: Study 1, an online question-
naire of Australian infection control practitioners (N= 35), sought ratings of the 
absolute and relative importance of a range of barriers and facilitators of using 
EE in healthcare decision making. Seven factors (rigor of the cost effectiveness 
analysis, quality of the clinical evidence, timeliness, communication, applicabil-
ity, conflicts of interest, equity) were selected from this study to inform Study 2. 
Study 2 used a discrete choice experiment (blocked, orthogonal design) to examine 
the relative importance of these seven factors in the choice between two health 
economists which differ in these attributes. This was administered online to a 
range of Australian healthcare decision makers. RESULTS: Study 1 showed that 
quality of clinical evidence was the most important factor when examining EE, 
followed by applicability, communication, and the rigour of the cost effectiveness 
analysis. Conflict of interest was the least important factor. Study 2 will demon-
strate the trade-offs between these factors. The results for this second study will 
be ready in March. CONCLUSIONS: This research shows which factors are most 
valuable for healthcare decision makers using EE. To our knowledge this is the 
first study to use a preference analytic technique to measure what is valuable in 
a decision tool. The findings from this research will provide guidance on how to 
better deliver EE to end users.
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OBJECTIVES: Public health policies rely largely on observational studies developed 
through the compilation of real world data. From the access and health technol-
ogy assessment (HTA) perspectives, real world data are an essential ancillary tool 
in decision-making, providing information on burden of disease, cost-of-illness, 
resource usage, treatment patterns, compliance, natural history of the disease, 
effectiveness and safety. The Brazilian Network for Health Technology Assessment 
(REBRATS) recommends the use of observational studies to develop economic 
evaluations for both effectiveness and safety data. However, the extent of use 
of such data in Brazil remains undetermined. Our objective was to identify the 
requirements and needs for epidemiological data regarding HTA submissions in 
Brazil. METHODS: We reviewed HTA requirements, reports and dossiers from the 
Brazilian HTA commission (CONITEC) for epidemiological data aimed at incor-
poration. Additionally, we searched Brazilian guidelines and regulations about 
principles for real world data requirements for HTA. RESULTS: CONITEC issued 
119 reports between the time of its establishment (April/2011) and the date of 
our analysis (December 08th, 2014). The Committee reported lack of real world 
studies in 11.8% of the submissions (14 of 119 reports), including the need of 
epidemiological studies (prevalence and incidence) (n= 8), safety and efficacy tri-
als (n= 3), safety study (n= 1), epidemiological and clinical characteristics studies 
(n= 1) and resource use and cost-of-illness analyses (n= 1). The lack of epidemio-
logic data was the most common issue (8 of 14 reports). However, real world data 
regarding safety, effectiveness and clinical characteristics were also critical (7 of 
14 reports). CONCLUSIONS: Our analysis showed that use of real world data in 
Brazil remains an unmet need for HTA.
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OBJECTIVES: Low cost generic programs (LCGPs) offer an affordable means to 
obtain medications which can be used to treat a myriad of acute and chronic 
conditions. However, since the medications are often purchased without using 
insurance, a claim will never be adjudicated. Thus, medication use may go unob-
served in administrative claims data, which are often used for research and quality 
control initiatives. This study sought to assess the characteristics and prevalence 
associated with LCGP use in the Medicare insured population. METHODS: Using 
data from the Medical Expenditure Panel Survey from 2006-2011, individuals 
were classified as LCGP users or non-users based on payment variables from 
pharmacy records. Demographics of users and non-users were compared includ-
ing age, gender, prescription drug coverage, and health-related characteristics. 
A multivariable logistic regression model was estimated to identify the charac-
teristics with the greatest association with use. RESULTS: With a total cohort of 
N= 9,906, 48.03% were classified as users. Half of the individuals with prescrip-
tion insurance coverage utilized these programs compared to nearly one-third 
of those without prescription coverage. The user group also used more medi-
cations per-person over the two-year period (77.20 vs 53.35, p< 0.01) and more 
unique medications (12.68 vs 8.71, p< 0.01). The user group also had higher 
average Charlson Comorbidity Index scores (1.75 vs 1.30, p< 0.01). In adjusted 
analyses, individuals with prescription insurance had 39% higher odds of using 
LCGPs. Each additional unique medication was associated with a 9% increase in 
the odds of being a user (OR 1.09, 95% CI 1.08 – 1.10). LCGP use was also associ-
ated with increasing income levels but not associated with increasing comor-
bidity scores. CONCLUSIONS: Nearly one-half of all Medicare insured persons 
used LCGPs during the study period. This may misrepresent exposure classifi-
cation when research or quality initiatives are based on administrative claims 
data.
materials for dissemination. METHODS: We surveyed HEOR professionals to gauge 
their perspective on the quality of HEOR communications materials. A 16-question 
on-line survey was sent to 300 HEOR professionals in July 2014. Descriptive analyses 
were conducted as appropriate. RESULTS: Fifty-nine surveys were returned fully or 
partially completed. Eighty-eight percent of respondents have advanced degrees, 
43% are employed by bio/pharma companies, 78% are HEOR directors or manag-
ers and 50% had more than 3 years in their current position. Forty-seven percent 
of respondents use internal medical writing teams and 62% subcontract writing to 
outside vendors. Dossiers are the most frequent item outsourced at 45%. Forty percent 
of respondents indicated that they outsource manuscripts and 25% of respondents 
outsource abstracts. Consistently across several quality measures, approximately 
55% of respondents are not satisfied with the quality of writing for their communi-
cation materials. Improvement in value messaging and methodology were the two 
most cited areas of concern about writing quality beyond the general question about 
satisfaction with overall writing quality. CONCLUSIONS: More than 50% of HEOR 
executive respondents seek better quality in written documents and more appropri-
ate terminology in addressing their business objectives with scientifically rigorous 
content. Therefore, it is apparent from these survey results that HEOR directors and 
managers consider nearly half of all their communications to not be well-written.
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OBJECTIVES: Effective communication of risk of medication side effects is neces-
sary in order to minimize its misinterpretation and over-estimation by patients. 
The study evaluated effect of communication style (verbal vs verbal + numeric) on 
perception of risk of experiencing medication side effects of different frequency and 
severity levels. METHODS: Participants were randomly presented with information 
on medication side effects using either verbal (e.g. ‘rarely’) or verbal + numeric (e.g. 
‘rarely i.e. 2 out of 100’) communication style for frequency descriptions, in a 2 (com-
munication style: verbal, verbal combined with numeric frequency) X 2 (side effect 
frequency: low, high) X 2 (side effect severity: mild, severe) experimental design. 
Perception of risk of experiencing side effects was measured and test for analysis 
of variance was performed. RESULTS: Communication style was observed to sig-
nificantly affect risk perception for certain combinations of severity and frequency. 
It was observed that with combined communication style (verbal + numeric), risk 
perception of severe side effects of low frequency decreased (mean difference: 11.24; 
C.L.: 4.60 – 17.82) whereas that of mild side effects of high frequency side increased 
(mean difference: 7.80; C.L.: 1.21 – 14.39) as compared to only verbal communication 
style. It was also observed that the low and high frequency side effects were better 
distinguished with respect to their risk when combined communication style was 
used (mean risk perception difference between low and high frequency side effects: 
36.24; C.L.: 31.58 – 40.89) as compared to verbal only (mean difference: 22.2; C.L.: 
17.53 – 26.84). Significant main effects of frequency and severity on risk perception 
were also observed. CONCLUSIONS: Use of numeric frequencies along with ver-
bal descriptions of risk of medication side effect helps in better understanding of 
underlying risk and reduces its over-estimation, especially for low frequency side 
effects. Healthcare professionals should take into consideration these effects while 
communicating side-effect risks to their patients.
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OBJECTIVES: In 2006 a number of studies were conducted in Kazakhstan with 
UNICEF, which have shown that the majority of children in children’s homes are at 
risk of essential nutrients deficiency. So we have investigated a nutrition adequacy 
according to the body needs of the orphans and children left without parental 
care in children’s homes of the health care system. METHODS: Were included 226 
children from national orphan homes in Akmola and Almaty regions in the ages 
of 6 to 36 months. The study did not include children with disabilities or severe 
diseases. 100 children (57 boys, 43 girls) from the families in organized groups 
were taken as control group. Were evaluated a physiological status, hemoglobin, 
morphofunctional status of the children, also the analysis of food packages and 
the chemical composition of the diet were done. Malnutrition was calculated by 
“Anthro” program (WHO, 2006). RESULTS: Birth weight corresponded to normal in 
67% of children under parental care and 33% of orphans, 56% of orphans are lag-
ging in teething development, in the control group was no lag (1%). 15% of orphans 
have clinical manifestations of changes in the skin, mucous membranes and bone. 
Consumption of the main types of products (primarily meat, milk, fish, vegetables 
and fruit) in children’s homes was below current standards and recommendations 
of the Kazakh Academy of Nutrition, based on international experience. Because of 
inadequate food intake, the orphans have an expressed protein deficit (25%), PUFAs 
(32%), vitamin A (44%), pyridoxine (45%), pantothenic acid (53%), vitamin B12 (37 %), 
ascorbic acid (59%) and copper. CONCLUSIONS: Analysis showed that the actual 
children nutrition scheme is obsolete and needs to be revised in a short time. The 
study will have indices of more in-depth clinical examination and QoL evaluation 
with further economical calculation (budget impact, etc.)
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those of EU and IDF criteria were 91.8% and 86.9% respectively. Similarly the NPV 
was highest for the NCEP criteria followed by the EU (99.3%) and IDF (98.3%) criteria. 
The kappa-statistics showed highest agreement with the NCEP criteria (kappa= 0.90) 
while the IDF (kappa= 0.46) and EU criteria (kappa= 0.33) displayed moderate and 
fair levels of agreement respectively with the WHO criteria. CONCLUSIONS: Our 
findings demonstrate that NCEP criteria displayed best performance parameters 
relative to WHO criteria and may serve as alternative to the WHO criteria when 
comparing other definitions used in older studies to current studies.
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in tHeiR oWn WoRds: social listening foR “Real-WoRld Benefits” 
fRom PRescRiPtion and otc PRoducts
Powell G.E., Duke S.P., Bell H.G., Anderson L.S., Metcalf M.A.
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OBJECTIVES: The objective of this study was to evaluate “real-world benefit” dis-
cussions from publically available de-identified sources (social media and internet 
forums) that can be obtained through social listening. METHODS: A third party 
vendor collected posts from Facebook and Twitter over the previous year for a variety 
of 15 prescription and over-the-counter (OTC) products. Data vocabularies were 
standardized using a vernacular to MedDRA dictionary for medical conditions and 
a custom curated vernacular dictionary for drugs and OTC products. Next, noise 
was systematically removed via natural language processing and each post was 
characterized as a Mention (drug mentioned but no adverse events) or a Proto AEs 
(potential adverse event mentioned within the context of drug use). Finally, the data 
was de-identified prior to making it available to the research team who then man-
ually reviewed each post and collected “real-world benefit” attributes. RESULTS: 
Overall 2159/7529 (29%) of Mentions and Proto AEs contained “real-world benefit” 
information; of the 2159 posts, 1207 (56%) were positive benefits discussions and 
952 (44 %) discussed lack of effect. Of the positive benefits discussions (N= 1207), 94 
(8%) contained benefit time-to-onset, 28 (2%) contained duration of benefit, 125 (10%) 
indicated partial benefit, 514 (43%) indicated full benefit, 37 (3%) contained benefits 
discussion within the context of cost, 196 (16%) contained benefits discussion within 
the context of adverse events, and 138 (11%) contained benefits information as com-
pared to other treatment options. CONCLUSIONS: Social listening has the potential 
to provide a large amount of information about “real-world benefit” as discussed 
from the consumers’/patients’ perspective. This is the first step in understanding 
how Social Listening can contribute to better characterization of benefit/risk profiles 
using the consumers’ own voice.
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OBJECTIVES: Prevalence of potentially inappropriate prescribing (PIP) of harmful 
medications in the elderly has been widely investigated, but it remains unclear 
whether PIP is predictive of adverse events. Our study objective was to determine 
whether exposure to PIP is linked to increased rates of hospitalization and mortal-
ity. METHODS: We performed a retrospective analysis using the Italian Regione 
Emilia-Romagna (RER) longitudinal administrative healthcare database of all elderly 
patients (≥ 65 years) from 2003 to 2013. The RER database includes de-identified, 
fully-linkable demographic, hospital, and pharmacy claims data for all residents 
in the region. PIP exposure initiated upon the dispensing of a medication that 
“should always be avoided” based on the Maio criteria. To estimate PIP exposure 
we computed the number of days supplied for each medication of interest (using 
Defined Daily Doses) plus 30 days. An exposure period spanned the duration of 
consecutive PIP dispensings. An event, the composite outcome of hospitalization 
or death, was attributed to PIP if it occurred during an exposure period. Rate ratios 
and 95% confidence intervals (CI) were estimated by Poisson generalized estimat-
ing equations modeling. RESULTS: The 1,471,179 elderly individuals living in the 
RER contributed a total of 10,369,120 person-years (PY) of follow-up time and expe-
rienced a total of 1,973,878 events. The unadjusted event rate was 1.572 (95% CI: 
1.562, 1.580) times greater among patients exposed to PIP compared to those not 
exposed (2.87 events/10 PY vs. 1.82 events/10 PY). The unadjusted mortality rate was 
1.473 (95% CI: 1.458, 1.488) times greater with PIP exposure (0.51/10 PY vs. 0.35/10 
PY). CONCLUSIONS: These results indicate that exposure to PIP may be associated 
with higher hospitalization and mortality rates in elderly patients. This analysis, 
using a large cohort of patients, sheds light on the importance of reducing PIP in 
this population.
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nigeRian teacHing HosPital
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OBJECTIVES: Adverse Events (AEs) has proven to be a significant cause of hospi-
tal admissions, with prevalence rate ranging from 6.5-26.1% and this constitute a 
significant problem with serious consequences and a challenge for public health. 
This intensive study is aimed at determining the prevalence of AEsas well as to 
assess the cause, nature, severity, preventability and outcomes in a Nigerian teach-
ing hospital and to determine the class of suspected drugs most commonly impli-
cated. METHODS: A three months observational study of 221 consecutive adult 
patients of the Lagos University Teaching Hospital medical in-patient ward and 
out-patient clinic. Epi-info statistical software, (Version 3.4.3, 2007) was used to 
analyze and determine prevalence, causality, severity and preventability. A sig-
nificance level of p < 0.05 was used. RESULTS: The prevalence of AEs was 17.6% 
(95% CI; 12.9, 23.3) with 30 (79.5%) of these presenting at admission and 8(20.5%) 
developing during hospitalization. The World Health Organization (WHO) causality 
PHP90
RelationsHiP BetWeen tHe develoPment of electRonic HealtH 
RecoRds and HosPital accReditation decisions in fRance: Results 
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OBJECTIVES: To make eHealth technology more efficient, particularly for the qual-
ity and safety of care, the French Ministry of Health (DGOS) launched the national 
“Hopital numérique 2012-2017” program, a strategic development plan for the 
modernization of health information technology. The aim of this study was to 
assess the impact of the development of electronic health records (EHR) on the 
accreditation results of French hospitals performed by the HAS (French National 
Authority for Health). METHODS: This retrospective study included all of the acute 
care hospitals accredited between October 2012 and April 2014. Three national data-
bases were used: national accreditation database, oSIS (observatoire des systèmes 
d’information de santé-2012), and IPAQSS (indicateurs pour l’amélioration de la 
qualité et la sécurité des soins-2012). National data were provided by the DGOS and 
HAS, together with methodological support. We developed an ordered Logit model, 
where the polytomous dependent variable was ordered according to the follow-
ing descriptions: full accreditation, recommendation, reservation, or delay in the 
accreditation decision. The independent variables were the proportion of EHR used 
(full, partial, or no EHR); type of hospital (teaching, private non-profit, for-profit, or 
other public hospital); accuracy of the care, with versus without home care hospi-
talization; and geographic region. RESULTS: The study included 679 hospitals; 21% 
had full accreditation, 45% recommendation, 25% reservation, and 9% a delay in 
accreditation. We found that the higher the number of full EHR used, the better the 
accreditation decision (p< 0.001). We also observed that the higher the number of 
partial EHR used, the better the accreditation decision (p= 0.002). Finally, the accredi-
tation decision was also better for for-profit hospitals (p< 0.001), private non-profit 
hospitals (p= 0.005), and in the southeast of France (p= 0.02). CONCLUSIONS: Our 
findings suggest that the development of EHR in acute care hospitals is associated 
with a higher performance in accreditation decisions in France.
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OBJECTIVES: In 1998, the Food and Drug Administration (FDA) Adverse Event 
Reporting System (FAERS) (formerly AERS) was launched by the FDA as a post-
marketing safety surveillance program to capture adverse drug events (ADEs) and 
medication errors. From 1998 to 2005, it was found that the number of serious and 
fatal ADEs reported to the FDA increased by 2.6-fold and 2.7-fold, respectively. The 
purpose of this study was to document current trends in serious and fatal ADE 
reports. METHODS: We conducted a retrospective analysis of the 2006-2011 FAERS 
database. Information on patient demographics, primary suspect drug, outcomes, 
and other variables were obtained from data files. Non-US reports and reports 
from clinical trials were excluded. Outcomes were recoded into three categories: 
death, disability (disability or congenital anomaly), and all other serious outcomes 
(hospitalizations, requiring intervention, or life-threatening, or other serious out-
comes). We determined the number of reports by year, the types and sources of 
reports, and age-wise distribution of serious ADEs. A list of drugs with more than 
1,000 reports of serious ADEs was compiled and subgroups of important drugs 
were identified RESULTS: A total of 245,265 reports of deaths (53,447), disabilities 
(20,305), and other serious outcomes (171,513) were reported representing 206,087 
person-reports. The percentage of reports involving death increased from 17.3% in 
2006 to 27.0% in 2011. Analgesics, antihypertensives, and antipsychotics were the 
most common drugs involved in serious reports of ADEs. Drugs with more than 
1,000 serious reports of ADEs included 2 drugs currently withdrawn from market, 4 
drugs under the FDA Risk Evaluation and Mitigation Strategies (REMS) program, 11 
specialty drugs, 3 biologic drugs, and others. CONCLUSIONS: A substantial number 
of serious ADEs were reported from 2006-2011. Drugs under the REMS program, spe-
cialty drugs, and biologic drugs contribute to a significant number of serious ADEs.
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OBJECTIVES: Numerous diagnostic criteria of the metabolic syndrome exist 
including the recent 2009 World Health Organization definition, criteria for 
National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III), 
International Diabetes Federation (IDF) and European Group for Study of Insulin 
Resistance (EGIR). The multiplicity of definitions makes comparing studies with 
older criteria difficult. Our objective was to compute sensitivity, specificity, posi-
tive (PPV) and negative predictive values (NPV) and level of agreement between 
WHO standard and other definitions to determine which criteria performs best 
when comparing estimates from previous studies. METHODS: The NHANES 2009-10 
and 2011-2012 demographics, examination and laboratory data formed our cohort. 
Prevalence estimates using all criteria were calculated. Sensitivity, specificity, PPV 
and NPV of all criteria keeping the WHO criteria as gold standard were computed. 
Kappa statistics to determine strength of agreement between WHO criteria relative 
to other definitions were estimated. RESULTS: WHO criteria yielded the highest 
prevalence at 22.2% followed by NCEP (19.1%), IDF (9.8%) and EU criteria (6.2%). 
Sensitivity of the NCEP criteria was the highest at 86.2% followed by IDF (38.6%) 
and EU (25.9%) criteria. Specificity of the NCEP criteria was highest at 100% followed 
by EU (99.3%) and IDF (98.3%) criteria. The PPV of the NCEP criteria was 100% while 
